Who is sponsoring NCT05122741?

NCT05122741 is sponsored by University of Messina.

What drugs are being tested in NCT05122741?

Interventions in NCT05122741: P2Y12 Potent Inhibitor + Aspirin for STEMI patients, Clopidogrel + Aspirin for CCS patients.

What condition does NCT05122741 study?

NCT05122741 studies Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular.

Is NCT05122741 still recruiting?

NCT05122741 is currently status unknown. Last updated 25 January 2023.

Last reviewed 2023-01-25 · How we verify

NCT05122741: BETA-MI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modulation of Fibrosis-inducing Pathways in Acute Myocardial Infarction

Status unknown Last updated 25 January 2023

What this trial tests

trial testing P2Y12 Potent Inhibitor + Aspirin for STEMI patients in Myocardial Infarction in 50 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
1 November 2023

31 December 2023

Quick facts

Lead sponsor	University of Messina
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 December 2021
Primary completion	1 November 2023
Estimated completion	31 December 2023
Sites	1 location across Italy

Drugs / interventions tested

P2Y12 Potent Inhibitor + Aspirin for STEMI patients — full drug profile →
Clopidogrel + Aspirin for CCS patients — full drug profile →

Conditions studied

Myocardial Infarction — all drugs for Myocardial Infarction →
Myocardial Fibrosis — all drugs for Myocardial Fibrosis →
Myocardial Remodeling, Ventricular — all drugs for Myocardial Remodeling, Ventricular →

Sponsor

University of Messina

Who can join

Eligibility, any sex, with Myocardial Infarction or Myocardial Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, prospective, observational controlled cohort study designed to describe the role of WNT/B-catenin signaling and adenosine system after an acute myocardial infarction, correlating it with clinical markers of fibrosis/remodeling (primary objective). The modulation of the aforementioned molecular patterns will also be evaluated in light of the type of P2Y12 inhibitor implemented (ticagrelor or prasugrel) to identify variations in response (secondary objective).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting

Other University of Messina trials

Trials by the same sponsor.

NCT07106463 — Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic M · active not recruiting
NCT05496322 — Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure · NA · completed
NCT04994379 — Investigating the Effects of Intensity of Transcranial Direct Current Stimulation on Subjective Appetite · NA · terminated
NCT06787781 — Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects · NA · completed
NCT04751565 — Non Surgical Peri-implant Mucositis Treatment in Patients With Tissue-level and Bone-level Implants · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05122741 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Messina
Last refreshed: 25 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing